These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25621111)

  • 1. Methods of induced pluripotent stem cells for clinical application.
    Seki T; Fukuda K
    World J Stem Cells; 2015 Jan; 7(1):116-25. PubMed ID: 25621111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
    Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
    Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
    Kramer AS; Harvey AR; Plant GW; Hodgetts SI
    Cell Transplant; 2013; 22(4):571-617. PubMed ID: 22944020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprint of "iPSCs, aging and age-related diseases".
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2015 Jan; 32(1):169-79. PubMed ID: 25479728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
    Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
    Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin.
    Yan X; Xu N; Meng C; Wang B; Yuan J; Wang C; Li Y
    Am J Transl Res; 2016; 8(2):419-32. PubMed ID: 27158336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming.
    Ji P; Manupipatpong S; Xie N; Li Y
    Stem Cells Int; 2016; 2016():8415010. PubMed ID: 26880993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
    Sun C; Wilson GS; Fan JG; Qiao L
    Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
    Hsu YC; Wu YT; Tsai CL; Wei YH
    Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of induced pluripotent stem cell technologies in spinal cord injury.
    Nagoshi N; Okano H
    J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
    Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
    J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.